> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# CDER Launches Controlled Substances Program
- URL: https://www.fdaweb.com/cder-launches-controlled-substances-program/
- Published: 2020-02-12T12:00:00.000Z
- Updated: 2026-09-14T16:02:53.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5146069

CDER has launched its new Controlled Substances Program (CSP) that encompasses the controlled substances staff and controlled substances initiatives. An internal staff [memo](http://www.fdaweb.com/download.php?file=throckmorton2-2020.docx) says the CSP was established to coordinate CDER activities and emerging issues around controlled substances including prescription opioids, benzodiazepines, and stimulants. The memo says the CSP will strengthen the Center’s ability to proactively pursue policies and initiatives to prevent or minimize the risks associated with problematic use of controlled substances and to help enable appropriate access to the products for medical use.

The program is said to give CDER the capability to **(1)** coordinate and support the Center’s work on controlled substance policies and programs with internal and external stakeholders; **(2)** facilitate intra- and inter-agency interactions to develop and implement strategies for appropriate access; and **(3)** provide technical expertise on specific drug applications and drug scheduling.